A proteomic analysis of an in vitro knock-out of miR-200c

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• MicroRNA-200c (miR-200c) loss correlates with advanced cancer and reduced chemotherapy effectiveness.
• MicroRNAs regulate numerous target genes, making proteomic analysis crucial after genomic alterations.
• Understanding miR-200c's role requires examining protein expression changes post-knockout.

Purpose of the Study:

• To investigate the proteomic impact of miR-200c genomic knockout in MCF7 breast cancer cells.
• To identify key proteins and pathways affected by miR-200c loss.
• To correlate protein expression changes with observed biological phenotypes.

Main Methods:

• Generated a TALENs-mediated genomic knockout (KO) of miR-200c in MCF7 cells.
• Analyzed the proteome of three independent miR-200c KO clones.
• Confirmed differential protein expression at the mRNA level for selected targets.

Main Results:

• Identified 26 key differentially expressed proteins.
• Detected significant enrichments in metabolic and cytoskeletal pathways.
• Observed increased cell migration, chemoresistance, and altered metabolism in miR-200c KO clones.
• Confirmed differential expression for AGR2, FLNA/B, ALDH7A1, SCIN, and GSTM3 at both protein and mRNA levels.

Conclusions:

• Proteomic alterations following miR-200c KO explain observed phenotypes like increased migration and chemoresistance.
• Findings provide novel insights into miR-200c function in breast cancer.
• Identified protein targets offer avenues for future research into miR-200c's role.